Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Published Online
on May 3, 2004

Circulation. 2004
Published online before print May 3, 2004, doi: 10.1161/01.CIR.0000129088.49276.83
A more recent version of this article appeared on June 1, 2004
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
109/21/2554    most recent
01.CIR.0000129088.49276.83v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Schäfers, M.
Right arrow Articles by Levkau, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Schäfers, M.
Right arrow Articles by Levkau, B.
Related Collections
Right arrow Pathophysiology
Right arrow Imaging
Right arrow Nuclear cardiology and PET

© American Heart Association, Inc.

Basic Science Reports

Scintigraphic Imaging of Matrix Metalloproteinase Activity in the Arterial Wall In Vivo

Michael Schäfers, MD*; Burkhard Riemann, MD*; Klaus Kopka, PhD; Hans-Jörg Breyholz, PhD; Stefan Wagner, PhD; Klaus P. Schäfers, PhD; Marilyn P. Law, BSc; Otmar Schober, MD Bodo Levkau, MD

From the Department of Nuclear Medicine (M.S., B.R., K.K., H.-J.B., S.W., K.P.S., M.P.L., O.S.), Hospital of the Westfälische Wilhelms-University, Münster; Institute of Arteriosclerosis Research (M.S.), Westfälische Wilhelms-University, Münster; and Institut für Pathophysiologie (B.L.), Zentrum für Innere Medizin, Universitätsklinikum Essen, Germany.

Correspondence to Michael Schäfers, MD, Department of Nuclear Medicine–Experimental Nuclear Medicine, Albert-Schweitzer-Strasse 33, 48129 Münster, Germany. E-mail schafmi{at}uni-muenster.de

Received November 26, 2003; de novo received March 11, 2004; accepted March 11, 2004.

Background— Matrix metalloproteinases (MMPs) are enzymes involved in the proteolytic degradation of extracellular matrix. They play an important role in several disease processes, such as inflammation, cancer, and atherosclerosis.

Methods and Results— In this study, we have used the broad-spectrum MMP inhibitor CGS 27023A to develop the radioligand [123I]I-HO-CGS 27023A for in vivo imaging of MMP activity. Using this radioligand, we were able to specifically image MMP activity by scintigraphy in vivo in the MMP-rich vascular lesions that develop after carotid artery ligation and cholesterol-rich diet in apolipoprotein E–deficient mice. These results were confirmed by gamma counting of lesional tissue (counts per minute per milligram).

Conclusions— Imaging of MMP activity in vivo is feasible using radiolabeled MMP inhibitors. Additional studies are needed to test the potential of this approach as a novel noninvasive clinical diagnostic tool for the management of human MMP-related diseases.


Key Words: imaging • metalloproteinases • atherosclerosis • nuclear medicine




This article has been cited by other articles:


Home page
CirculationHome page
J. Zhang, L. Nie, M. Razavian, M. Ahmed, L. W. Dobrucki, A. Asadi, D. S. Edwards, M. Azure, A. J. Sinusas, and M. M. Sadeghi
Molecular Imaging of Activated Matrix Metalloproteinases in Vascular Remodeling
Circulation, November 4, 2008; 118(19): 1953 - 1960.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
H. F. Langer, R. Haubner, B. J. Pichler, and M. Gawaz
Radionuclide imaging a molecular key to the atherosclerotic plaque.
J. Am. Coll. Cardiol., July 1, 2008; 52(1): 1 - 12.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
E. Lancelot, V. Amirbekian, I. Brigger, J.-S. Raynaud, S. Ballet, C. David, O. Rousseaux, S. Le Greneur, M. Port, H. R. Lijnen, et al.
Evaluation of Matrix Metalloproteinases in Atherosclerosis Using a Novel Noninvasive Imaging Approach
Arterioscler. Thromb. Vasc. Biol., March 1, 2008; 28(3): 425 - 432.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
M. P. S. Dunphy, H. Schoder, and H. W. Strauss
Radionuclide Techniques for Identifying Vulnerable Plaque
J. Nucl. Med., November 1, 2007; 48(11): 1753 - 1755.
[Full Text] [PDF]


Home page
Physiol. Rev.Home page
F. G. Spinale
Myocardial Matrix Remodeling and the Matrix Metalloproteinases: Influence on Cardiac Form and Function
Physiol Rev, October 1, 2007; 87(4): 1285 - 1342.
[Abstract] [Full Text] [PDF]


Home page
RadiologyHome page
J. C. Wu, F. M. Bengel, and S. S. Gambhir
Cardiovascular Molecular Imaging
Radiology, August 1, 2007; 244(2): 337 - 355.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
B. A. Kaufmann, J. M. Sanders, C. Davis, A. Xie, P. Aldred, I. J. Sarembock, and J. R. Lindner
Molecular Imaging of Inflammation in Atherosclerosis With Targeted Ultrasound Detection of Vascular Cell Adhesion Molecule-1
Circulation, July 17, 2007; 116(3): 276 - 284.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
J. R. Barbour, R. E. Stroud, A. S. Lowry, L. L. Clark, A. M. Leone, J. A. Jones, F. G. Spinale, and J. S. Ikonomidis
Temporal disparity in the induction of matrix metalloproteinases and tissue inhibitors of metalloproteinases after thoracic aortic aneurysm formation
J. Thorac. Cardiovasc. Surg., October 1, 2006; 132(4): 788 - 795.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
F. G. Spinale, G. P. Escobar, J. W. Hendrick, L. L. Clark, S. S. Camens, J. P. Mingoia, C. G. Squires, R. E. Stroud, and J. S. Ikonomidis
Chronic Matrix Metalloproteinase Inhibition Following Myocardial Infarction in Mice: Differential Effects on Short and Long-Term Survival
J. Pharmacol. Exp. Ther., September 1, 2006; 318(3): 966 - 973.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
J. R. Davies, J. H.F. Rudd, P. L. Weissberg, and J. Narula
Radionuclide imaging for the detection of inflammation in vulnerable plaques.
J. Am. Coll. Cardiol., April 18, 2006; 47(8 Suppl): C57 - C68.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
F. A. Jaffer, P. Libby, and R. Weissleder
Molecular and Cellular Imaging of Atherosclerosis: Emerging Applications
J. Am. Coll. Cardiol., April 4, 2006; 47(7): 1328 - 1338.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
C. M. Matter, M. T. Wyss, P. Meier, N. Spath, T. von Lukowicz, C. Lohmann, B. Weber, A. R. de Molina, J. C. Lacal, S. M. Ametamey, et al.
18F-Choline Images Murine Atherosclerotic Plaques Ex Vivo
Arterioscler. Thromb. Vasc. Biol., March 1, 2006; 26(3): 584 - 589.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
H. Su, F. G. Spinale, L. W. Dobrucki, J. Song, J. Hua, S. Sweterlitsch, D. P. Dione, P. Cavaliere, C. Chow, B. N. Bourke, et al.
Noninvasive Targeted Imaging of Matrix Metalloproteinase Activation in a Murine Model of Postinfarction Remodeling
Circulation, November 15, 2005; 112(20): 3157 - 3167.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
R. O. Bonow
Molecular Beacons Illuminate Subcellular Events
Circulation, April 12, 2005; 111(14): 1730 - 1732.
[Full Text] [PDF]


Home page
CirculationHome page
J. Chen, C.-H. Tung, J. R. Allport, S. Chen, R. Weissleder, and P. L. Huang
Near-Infrared Fluorescent Imaging of Matrix Metalloproteinase Activity After Myocardial Infarction
Circulation, April 12, 2005; 111(14): 1800 - 1805.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
R. J. Gibbons and P. A. Araoz
The year in cardiac imaging
J. Am. Coll. Cardiol., November 16, 2004; 44(10): 1937 - 1944.
[Full Text] [PDF]